Clinical Trial Keywords
breast cancer, biomarkers, survivorship
Selected Publications
Carlson, R.W.; Brown, E.; Burstein, H.J.; Gradishar, W.J.; Hudis, C.A.; Loprinzi, C.; Mamounas, E.P.; Perez, E.A.; Pritchard, K.; Ravdin, P.; Recht, A.; Somlo, G.; Theriault, R.L.; Winer, E.P.; Wolff, A.C. NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw. 2006 Mar;4 Suppl 1:S1-26.
Carlson, R.W.; Moench, S.J.; Hammond, M.E.; Perez, E
.A.; Burstein, H.J.; Allred, D.C.; Vogel, C.L.; Goldstein, L.J.; Somlo, G.; Gradishar, W.J.; Hudis, C.A.; Jahanzeb, M.; Stark, A.; Wolff, A.C.; Press, M.F.; Winer, E.P.; Paik, S.; Ljung, B.M. HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Natl Compr Canc Netw. 2006 Jul;4 Suppl 3:S1-22; quiz S23-24.
Khatcheressian, J.L.; Wolff, A.C.; Smith, T.J.; Grunfeld, E.; Muss, H.B.; Vogel, V.G.; Halberg, F.; Somerfield, M.R.; Davidson, N.E. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006 Nov 1;24(31):5091-5097.
Wolff, A.C.; Davidson, N.E. Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer. J Clin Oncol. 2006 Nov 1;24(31):4949-4951.
Wolff, A.C.; Jones, R.J.; Davidson, N.E.; Jeter, S.C.; Stearns, V. Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support. J Clin Oncol. 2006 May 20;24(15):2392-2394; author reply 2394-2395.
Briest, S.; Wolff, A.C. Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer. Expert review of anticancer therapy. 2007 Sep;7(9):1243-1253.
Carlson, R.W.; Anderson, B.O.; Burstein, H.J.; Carter, W.B.; Edge, S.B.; Farrar, W.B.; Goldstein, L.J.; Gradishar, W.J.; Hayes, D.F.; Hudis, C.A.; Jahanzeb, M.; Ljung, B.M.; Kiel, K.; Marks, L.B.; McCormick, B.; Nabell, L.M.; Pierce, L.J.; Reed, E.C.; Silver, S.M.; Smith, M.L.; Somlo, G.; Theriault, R.L.; Ward, J.H.; Winer, E.P.; Wolff, A.C. Invasive breast cancer. J Natl Compr Canc Netw. 2007 Mar;5(3):246-312.
Cianfrocca, M.; Wolff, A.C. Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer. Oncology (Williston Park). 2007 Jan;21(1):63-69; discussion 69, 72, 75 passim.
Messersmith, W.A.; Rudek, M.A.; Baker, S.D.; Zhao, M.; Collins, C.; Colevas, A.D.; Donehower, R.C.; Carducci, M.A.; Wolff, A.C. Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumours. Eur J Cancer. 2007 Jan;43(1):78-86.
Moore, H.C.; Green, S.J.; Gralow, J.R.; Bearman, S.I.; Lew, D.; Barlow, W.E.; Hudis, C.; Wolff, A.C.; Ingle, J.N.; Chew, H.K.; Elias, A.D.; Livingston, R.B.; Martino, S. Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623. J Clin Oncol. 2007 May 1;25(13):1677-1682.
Ouwerkerk, R.; Jacobs, M.A.; Macura, K.J.; Wolff, A.C.; Stearns, V.; Mezban, S.D.; Khouri, N.F.; Bluemke, D.A.; Bottomley, P.A. Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI. Breast Cancer Res Treat. 2007 Dec;106(2):151-160.
Tan, S.H.; Wolff, A.C. Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer. Clin Breast Cancer. 2007 Feb;7(6):455-464.
Wolff, A.C.; Hammond, M.E.; Schwartz, J.N.; Hagerty, K.L.; Allred, D.C.; Cote, R.J.; Dowsett, M.; Fitzgibbons, P.L.; Hanna, W.M.; Langer, A.; McShane, L.M.; Paik, S.; Pegram, M.D.; Perez, E.A.; Press, M.F.; Rhodes, A.; Sturgeon, C.; Taube, S.E.; Tubbs, R.; Vance, G.H.; van de Vijver, M.; Wheeler, T.M.; Hayes, D.F. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007 Jan 1;25(1):118-145.
Barone, B.B.; Yeh, H.C.; Snyder, C.F.; Peairs, K.S.; Stein, K.B.; Derr, R.L.; Wolff, A.C.; Brancati, F.L. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008 Dec 17;300(23):2754-2764.
Burstein, H.J.; Elias, A.D.; Rugo, H.S.; Cobleigh, M.A.; Wolff, A.C.; Eisenberg, P.D.; Lehman, M.; Adams, B.J.; Bello, C.L.; DePrimo, S.E.; Baum, C.M.; Miller, K.D. Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol. 2008 Apr 10;26(11):1810-1816.
Higgins, M.J.; Wolff, A.C. Therapeutic options in the management of metastatic breast cancer. Oncology (Williston Park). 2008 May;22(6):614-623; discussion 623, 627-619.
Marchionni, L.; Wilson, R.F.; Wolff, A.C.; Marinopoulos, S.; Parmigiani, G.; Bass, E.B.; Goodman, S.N. Systematic review: gene expression profiling assays in early-stage breast cancer. Ann Intern Med. 2008 Mar 4;148(5):358-369.
Snyder, C.F.; Garrett-Mayer, E.; Brahmer, J.R.; Carducci, M.A.; Pili, R.; Stearns, V.; Wolff, A.C.; Dy, S.M.; Wu, A.W. Symptoms, supportive care needs, and function in cancer patients: how are they related? Qual Life Res. 2008 Jun;17(5):665-677.
Sparano, J.A.; Wang, M.; Martino, S.; Jones, V.; Perez, E.A.; Saphner, T.; Wolff, A.C.; Sledge, G.W., Jr.; Wood, W.C.; Davidson, N.E. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med. 2008 Apr 17;358(16):1663-1671.
Tan, S.H.; Wolff, A.C. The role of ovarian ablation in the adjuvant therapy of breast cancer. Curr Oncol Rep. 2008 Jan;10(1):27-37.
Wolff, A.C.; Berry, D.; Carey, L.A.; Colleoni, M.; Dowsett, M.; Ellis, M.; Garber, J.E.; Mankoff, D.; Paik, S.; Pusztai, L.; Smith, M.L.; Zujewski, J. Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol. 2008 Feb 10;26(5):806-813.
Allred, D.C.; Carlson, R.W.; Berry, D.A.; Burstein, H.J.; Edge, S.B.; Goldstein, L.J.; Gown, A.; Hammond, M.E.; Iglehart, J.D.; Moench, S.; Pierce, L.J.; Ravdin, P.; Schnitt, S.J.; Wolff, A.C. NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. J Natl Compr Canc Netw. 2009 Sep;7 Suppl 6:S1-S21; quiz S22-23.
Baker, S.D.; Verweij, J.; Cusatis, G.A.; van Schaik, R.H.; Marsh, S.; Orwick, S.J.; Franke, R.M.; Hu, S.; Schuetz, E.G.; Lamba, V.; Messersmith, W.A.; Wolff, A.C.; Carducci, M.A.; Sparreboom, A. Pharmacogenetic pathway analysis of docetaxel elimination. Clin Pharmacol Ther. 2009 Feb;85(2):155-163.
Balmanoukian, A.; Zhang, Z.; Jeter, S.; Slater, S.; Armstrong, D.K.; Emens, L.A.; Fetting, J.H.; Wolff, A.C.; Davidson, N.E.; Jacobs, L.; Lange, J.; Tsangaris, T.N.; Zellars, R.; Gabrielson, E.; Stearns, V. African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women. J Clin Oncol. 2009 Aug 1;27(22):e35-37; author reply e38-39.
Carlson, R.W.; Allred, D.C.; Anderson, B.O.; Burstein, H.J.; Carter, W.B.; Edge, S.B.; Erban, J.K.; Farrar, W.B.; Goldstein, L.J.; Gradishar, W.J.; Hayes, D.F.; Hudis, C.A.; Jahanzeb, M.; Kiel, K.; Ljung, B.M.; Marcom, P.K.; Mayer, I.A.; McCormick, B.; Nabell, L.M.; Pierce, L.J.; Reed, E.C.; Smith, M.L.; Somlo, G.; Theriault, R.L.; Topham, N.S.; Ward, J.H.; Winer, E.P.; Wolff, A.C. Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2009 Feb;7(2):122-192.
Connolly, R.; Wolff, A.C. Pregnancy and fertility with breast cancer: what are the options? Oncology (Williston Park). 2009 May;23(6):478, 481.
Emens, L.A.; Asquith, J.M.; Leatherman, J.M.; Kobrin, B.J.; Petrik, S.; Laiko, M.; Levi, J.; Daphtary, M.M.; Biedrzycki, B.; Wolff, A.C.; Stearns, V.; Disis, M.L.; Ye, X.; Piantadosi, S.; Fetting, J.H.; Davidson, N.E.; Jaffee, E.M. Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation. J Clin Oncol. 2009 Dec 10;27(35):5911-5918.
Kantsiper, M.; McDonald, E.L.; Geller, G.; Shockney, L.; Snyder, C.; Wolff, A.C. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009 Nov;24 Suppl 2:S459-466.
Muss, H.B.; Berry, D.A.; Cirrincione, C.T.; Theodoulou, M.; Mauer, A.M.; Kornblith, A.B.; Partridge, A.H.; Dressler, L.G.; Cohen, H.J.; Becker, H.P.; Kartcheske, P.A.; Wheeler, J.D.; Perez, E.A.; Wolff, A.C.; Gralow, J.R.; Burstein, H.J.; Mahmood, A.A.; Magrinat, G.; Parker, B.A.; Hart, R.D.; Grenier, D.; Norton, L.; Hudis, C.A.; Winer, E.P. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009 May 14;360(20):2055-2065.
Partridge, A.H.; Wolff, A.C.; Marcom, P.K.; Kaufman, P.A.; Zhang, L.; Gelman, R.; Moore, C.; Lake, D.; Fleming, G.F.; Rugo, H.S.; Atkins, J.; Sampson, E.; Collyar, D.; Winer, E.P. The impact of sharing results of a randomized breast cancer clinical trial with study participants. Breast Cancer Res Treat. 2009 May;115(1):123-129.
Snyder, C.F.; Frick, K.D.; Kantsiper, M.E.; Peairs, K.S.; Herbert, R.J.; Blackford, A.L.; Wolff, A.C.; Earle, C.C. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009 Mar 1;27(7):1054-1061.
Snyder, C.F.; Frick, K.D.; Peairs, K.S.; Kantsiper, M.E.; Herbert, R.J.; Blackford, A.L.; Wolff, A.C.; Earle, C.C. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med. 2009 Apr;24(4):469-474.
Snyder, C.F.; Garrett-Mayer, E.; Blackford, A.L.; Brahmer, J.R.; Carducci, M.A.; Pili, R.; Stearns, V.; Wolff, A.C.; Dy, S.M.; Wu, A.W. Concordance of cancer patients'' function, symptoms, and supportive care needs. Qual Life Res. 2009 Oct;18(8):991-998.
Stein, K.B.; Snyder, C.F.; Barone, B.B.; Yeh, H.C.; Peairs, K.S.; Derr, R.L.; Wolff, A.C.; Brancati, F.L. Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2009 Sep 3.
Zellars, R.C.; Stearns, V.; Frassica, D.; Asrari, F.; Tsangaris, T.; Myers, L.; DiPasquale, S.; Lange, J.R.; Jacobs, L.K.; Emens, L.A.; Armstrong, D.K.; Fetting, J.H.; Garrett-Mayer, E.; Davidson, N.E.; Wolff, A.C. Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer. J Clin Oncol. 2009 Jun 10;27(17):2816-2822.
Barone, B.B.; Yeh, H.C.; Snyder, C.F.; Peairs, K.S.; Stein, K.B.; Derr, R.L.; Wolff, A.C.; Brancati, F.L. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care. 2010 Apr;33(4):931-939.
Chavez-Macgregor, M.; Litton, J.; Chen, H.; Giordano, S.H.; Hudis, C.A.; Wolff, A.C.; Valero, V.; Hortobagyi, G.N.; Bondy, M.L.; Gonzalez-Angulo, A.M. Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity. Cancer. 2010 Sep 1;116(17):4168-4177.
Chumsri, S.; Jeter, S.; Jacobs, L.K.; Nassar, H.; Armstrong, D.K.; Emens, L.A.; Fetting, J.H.; Lange, J.R.; Riley, C.; Tsangaris, T.N.; Wolff, A.C.; Zellars, R.; Zhang, Z.; Stearns, V. Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer. Clin Breast Cancer. 2010 Feb;10(1):40-45.
Hammond, M.E.; Hayes, D.F.; Dowsett, M.; Allred, D.C.; Hagerty, K.L.; Badve, S.; Fitzgibbons, P.L.; Francis, G.; Goldstein, N.S.; Hayes, M.; Hicks, D.G.; Lester, S.; Love, R.; Mangu, P.B.; McShane, L.; Miller, K.; Osborne, C.K.; Paik, S.; Perlmutter, J.; Rhodes, A.; Sasano, H.; Schwartz, J.N.; Sweep, F.C.; Taube, S.; Torlakovic, E.E.; Valenstein, P.; Viale, G.; Visscher, D.; Wheeler, T.; Williams, R.B.; Wittliff, J.L.; Wolff, A.C. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010 Jun 1;28(16):2784-2795.
Hammond, M.E.; Hayes, D.F.; Wolff, A.C.; Mangu, P.B.; Temin, S. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. J Oncol Pract. 2010 Jul;6(4):195-197.
Jacobs, M.A.; Stearns, V.; Wolff, A.C.; Macura, K.; Argani, P.; Khouri, N.; Tsangaris, T.; Barker, P.B.; Davidson, N.E.; Bhujwalla, Z.M.; Bluemke, D.A.; Ouwerkerk, R. Multiparametric magnetic resonance imaging, spectroscopy and multinuclear ((2)(3)Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Acad Radiol. 2010 Dec;17(12):1477-1485.
Partridge, A.H.; Archer, L.; Kornblith, A.B.; Gralow, J.; Grenier, D.; Perez, E.; Wolff, A.C.; Wang, X.; Kastrissios, H.; Berry, D.; Hudis, C.; Winer, E.; Muss, H. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol. 2010 May 10;28(14):2418-2422.
Snyder, C.F.; Blackford, A.L.; Brahmer, J.R.; Carducci, M.A.; Pili, R.; Stearns, V.; Wolff, A.C.; Dy, S.M.; Wu, A.W. Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30. Qual Life Res. 2010 Aug;19(6):837-845.
Snyder, C.F.; Stein, K.B.; Barone, B.B.; Peairs, K.S.; Yeh, H.C.; Derr, R.L.; Wolff, A.C.; Carducci, M.A.; Brancati, F.L. Does pre-existing diabetes affect prostate cancer prognosis? A systematic review. Prostate Cancer Prostatic Dis. 2010 Mar;13(1):58-64.
Stein, K.B.; Snyder, C.F.; Barone, B.B.; Yeh, H.C.; Peairs, K.S.; Derr, R.L.; Wolff, A.C.; Brancati, F.L. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci. 2010 Jul;55(7):1839-1851.
Peairs, K.S.; Barone, B.B.; Snyder, C.F.; Yeh, H.C.; Stein, K.B.; Derr, R.L.; Brancati, F.L.; Wolff, A.C. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011 Jan 1;29(1):40-46.
